| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Kazia Therapeutics Limited (NASDAQ: KZIA)
KZIA Technical Analysis
5
| As on 9th Jun 2023 KZIA STOCK Price closed @ 1.28 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 4.55 & Strong Sell for SHORT-TERM with Stoploss of 7.35 we also expect STOCK to react on Following IMPORTANT LEVELS. |
KZIASTOCK Price
| Open | 1.29 | Change | Price | % |
| High | 1.35 | 1 Day | -0.04 | -3.03 |
| Low | 1.28 | 1 Week | 0.09 | 7.56 |
| Close | 1.28 | 1 Month | -0.08 | -5.88 |
| Volume | 9987 | 1 Year | -6.32 | -83.16 |
| 52 Week High 8.65 | 52 Week Low 0.50 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| KZIA Daily Charts |
KZIA Intraday Charts |
Whats New @ Bazaartrend |
KZIA Free Analysis |
|
|
KZIA Important Levels Intraday
| RESISTANCE | 1.41 |
| RESISTANCE | 1.37 |
| RESISTANCE | 1.34 |
| RESISTANCE | 1.32 |
| SUPPORT | 1.24 |
| SUPPORT | 1.22 |
| SUPPORT | 1.19 |
| SUPPORT | 1.15 |
KZIA Forecast May 2024
| 4th UP Forecast | 5.71 |
| 3rd UP Forecast | 4.29 |
| 2nd UP Forecast | 3.41 |
| 1st UP Forecast | 2.53 |
| 1st DOWN Forecast | 0.03 |
| 2nd DOWN Forecast | -0.85 |
| 3rd DOWN Forecast | -1.73 |
| 4th DOWN Forecast | -3.15 |
KZIA Weekly Forecast
| 4th UP Forecast | 3.23 |
| 3rd UP Forecast | 2.60 |
| 2nd UP Forecast | 2.22 |
| 1st UP Forecast | 1.83 |
| 1st DOWN Forecast | 0.73 |
| 2nd DOWN Forecast | 0.34 |
| 3rd DOWN Forecast | -0.04 |
| 4th DOWN Forecast | -0.67 |
KZIA Forecast2024
| 4th UP Forecast | 17.47 |
| 3rd UP Forecast | 12.28 |
| 2nd UP Forecast | 9.07 |
| 1st UP Forecast | 5.86 |
| 1st DOWN Forecast | -3.3 |
| 2nd DOWN Forecast | -6.51 |
| 3rd DOWN Forecast | -9.72 |
| 4th DOWN Forecast | -14.91 |
Kazia Therapeutics Limited ( NASDAQ USA Symbol : KZIA )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
KZIA Business Profile
Kazia Therapeutics Limited, an oncology-focused biotechnology company, develops anti-cancer drugs. Its lead development candidate is Paxalisib, a small molecule, brain-penetrant inhibitor of the PI3K/Akt/mTor pathway, which is developed as a potential therapy for glioblastoma. It is also developing EVT801, an investigational new drug for various forms of cancer. The company was formerly known as Novogen Limited and changed its name to Kazia Therapeutics Limited in November 2017. Kazia Therapeutics Limited was incorporated in 1994 and is based in Sydney, Australia. Address: Three International Towers, Sydney, NSW, Australia, 2000
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service